Covid monoclonal antibody treatment outcomes for Native American patients

JAMA Network

What The Study Did: Researchers compared outcomes among high-risk Native American patients who did or didn’t receive monoclonal antibody treatment for COVID-19.

Authors: Ryan M. Close, M.D., M.P.H., of Whiteriver Indian Hospital in Whiteriver, Arizona, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2021.25866)

/Public Release. This material comes from the originating organization/author(s)and may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.